Release Date: July 31, 2025
Expiration Date: July 31, 2026
Activity Overview
This Community Practice Connection™ program provides an in-depth review of some highlights from the 16th Annual International Symposium on Ovarian Cancer and Other Gynecologic Malignancies™ held in May 2025. This unique and engaging multimedia activity is ideal for community-based clinicians and focuses on the practical aspects of managing patients with endometrial, cervical, and ovarian cancer, helping clinicians to place recent clinical trial data into context. The program is designed for those who did not attend the live meeting and to help reinforce learnings for those who did.
Target Audience
This educational activity is directed toward medical oncologists and fellows who treat patients with gynecologic malignancies. Gynecologic oncologists, surgical oncologists, pathologists, radiation oncologists, nurse practitioners, nurses, physician assistants, pharmacists, genetic counselors, researchers, and other health care professionals interested in treating gynecologic malignancies will be invited to participate.
Learning Objectives
Upon successful completion of this activity, you should be better prepared to:
- Understand how germline and somatic testing can guide treatment choices for gynecologic cancers
- Review the latest data on the effectiveness and safety of current and new therapies for gynecologic cancers
- Apply recent trial results and evolving treatment strategies, like targeted and immunotherapy, to patient care
- Learn strategies to prevent and manage adverse effects of treatments for gynecologic cancers
Kathleen Moore, MD, MS
Professor, Section of Gynecologic Oncology
Virginia Kerley Cade Endowed Chair in Cancer Development
Associate Director, Clinical Research
Director, Phase 1 Cancer Clinical Trials
Stephenson Cancer Center
The University of Oklahoma College of Medicine
Oklahoma City, OK
Disclosures: Consultant: Aadi Bioscience, AbbVie, AstraZeneca, BioNTech, Blueprint Medicines, Caris Life Sciences, Corcept Therapeutics, Daiichi Sankyo, Dualit, Eisai, GSK, Genentech/Roche, ImmunoGen, Janssen, Lilly, Merck, Mersana Therapeutics, Regeneron, Schrödinger, Scorpion Therapeutics, Takeda, Verastem Oncology, Zentalis Pharmaceuticals, Zymeworks
Ritu Salani, MD, MBA
Professor, Obstetrics and Gynecology
Director, Gynecologic Oncology
University of California, Los Angeles
Los Angeles, CA
Disclosures: Consultant: Daiichi Sankyo; Advisory Board: AbbVie, Eisai, GSK, Merck, Pfizer, Regeneron
Alexandra Leary, MD, PhD
President-Elect, GINECO Group
Deputy Head, Department of Medical Oncology
Medical Oncologist, Gynecology
Institut Gustave Roussy
Villejuif, France
Disclosures: Consultant/Advisory Board (paid to institution): Ability, AstraZeneca, Clovis, Eisai, Genmab, GSK, Merck Sharp & Dohme, Seagen, UltraHuman 8; Grant/Research Support (paid to institution): Ability, AstraZeneca, Bristol Myers Squibb, Clovis, GSK, Iovance, Merck Sharp & Dohme, OSE Immunotherapeutics, Roche, Sanofi, Seagen; Honoraria/Expenses: AstraZeneca, Clovis, GSK
Faculty, Staff, and Planners’ Disclosures
The staff of Physicians’ Education Resource®, LLC have no relevant financial relationships with ineligible companies.
PER® mitigated all COI for faculty, staff, and planners prior to the start of this activity by using a multistep process.
Off-Label Disclosure and Disclaimer
This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a health care professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER® or any company that provided commercial support for this activity.
GET STARTED WITH THIS PROGRAM:
Register now to gain access to this program.
Create AccountAlready Registered? Login Here
